Arecor Therapeutics (LSE:AREC) Net Margin % : -232.58% (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Arecor Therapeutics Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Arecor Therapeutics's Net Income for the six months ended in Jun. 2024 was £-4.64 Mil. Arecor Therapeutics's Revenue for the six months ended in Jun. 2024 was £2.00 Mil. Therefore, Arecor Therapeutics's net margin for the quarter that ended in Jun. 2024 was -232.58%.

The historical rank and industry rank for Arecor Therapeutics's Net Margin % or its related term are showing as below:

LSE:AREC' s Net Margin % Range Over the Past 10 Years
Min: -532.73 Med: -256.29 Max: -82.89
Current: -176.89

LSE:AREC's Net Margin % is ranked worse than
52.52% of 1013 companies
in the Biotechnology industry
Industry Median: -140.3 vs LSE:AREC: -176.89

Arecor Therapeutics Net Margin % Historical Data

The historical data trend for Arecor Therapeutics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arecor Therapeutics Net Margin % Chart

Arecor Therapeutics Annual Data

Trend

May17

May18

May19

Dec20

Dec21

Dec22

Dec23

Net Margin %

Get a 7-Day Free Trial

-325.53

-162.07

-532.73

-385.35

-187.05

Arecor Therapeutics Semi-Annual Data
	May18	May19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Net Margin %	Get a 7-Day Free Trial						-630.16	-286.14	-271.30	-138.64	-232.58

Competitive Comparison of Arecor Therapeutics's Net Margin %

For the Biotechnology subindustry, Arecor Therapeutics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arecor Therapeutics's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arecor Therapeutics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Arecor Therapeutics's Net Margin % falls into.

Arecor Therapeutics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Arecor Therapeutics's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-8.554	/	4.573
	=	-187.05 %

Arecor Therapeutics's Net Margin for the quarter that ended in Jun. 2024 is calculated as

Net Margin	=	Net Income (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	-4.64	/	1.995
	=	-232.58 %

Arecor Therapeutics (LSE:AREC) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Arecor Therapeutics Net Margin % Related Terms

Thank you for viewing the detailed overview of Arecor Therapeutics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Arecor Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arecor Therapeutics PLC (LSE:AREC) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

6UI:Germany

Address

Chesterford Research Park, Little Chesterford, Saffron Walden, GBR, CB10 1XL

Website

https://www.arecor.com

Arecor Therapeutics PLC is a focused biopharmaceutical company. The company is transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying an innovative proprietary formulation technology platform, Aresta. It is developing a portfolio of proprietary products in diabetes and other indications and working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their therapies. Geographically, it operates in the UK, Switzerland, Germany, Italy, the Rest of Europe, the USA, and India, out of which the majority is from the UK.